Filter By Category
Archives
Share on -
ARTEMOTIL
Generic Name: ARTEMOTIL
ABSTRACT -
Artemotil, also known as beta-arteether, is an oil-soluble semi-synthetic artemisinin derivative with rapid blood-schizonticidal antimalarial activity. It has been used in some regions as parenteral therapy for malaria but is not the preferred severe-malaria treatment in many current guidelines compared with artesunate-based regimens.
DOSAGE -
- Dosage should be determined by a clinician experienced in malaria treatment.
- Administration has historically been intramuscular using product-specific regimens; dose and schedule vary by country and label.
- Severe malaria requires urgent guideline-directed therapy and supportive care.
- Do not self-administer or use as prophylaxis.
SIDE EFFECTS–
- Injection-site pain, fever, nausea, vomiting, abdominal pain, or diarrhea
- Headache, dizziness, weakness, or fatigue
- Transient liver enzyme, hematologic, or ECG changes may occur
- Neurotoxicity concerns have been monitored in artemisinin derivative development
- Rash or hypersensitivity reactions
ALLERGIC REACTIONS -
- Allergy may present as rash, hives, swelling, wheezing, severe dizziness, or anaphylaxis.
- Severe reactions require immediate medical attention.
DRUG INTERACTIONS-
- Other antimalarials, QT-prolonging medicines, anticonvulsants, macrolides, fluoroquinolones, azoles, and hepatotoxic drugs require review.
- Avoid duplicate artemisinin derivative therapy unless part of a recommended regimen.
- Oil-based injections and co-administered medicines may affect tolerability.
PREAUTIONS–
- Confirm malaria diagnosis and severity; do not delay treatment in severe malaria.
- Assess pregnancy, age/weight, hepatic function, cardiac risk, and prior antimalarial exposure.
- Monitor parasitemia, fever clearance, neurologic status, and labs in severe disease.
- Transition to appropriate oral combination therapy as directed by guidelines.
WARNINGS –
- Severe malaria can be fatal and needs emergency care.
- Artemotil should not replace artesunate where artesunate is the recommended standard.
- Neurologic deterioration, severe allergy, or treatment failure requires urgent evaluation.
- Keep out of reach of children.
Share on -
. Developed by